The emergence of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable buzz within the healthcare community. This groundbreaking dual GIP and GLP-1 target medication appears to provide significant improvements in weight reduction compared to current therapies. Early research trials have demonstrated significant reductions in body fat per